chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse via medical assistant and refers to a 13-month-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 11-SEP-2017, the patient was vaccinated with improperly stored M-M-R II (lot # M034387; expiry date: 19-JUL-2018) (dosing details were not provided) for prophylaxis. Temperature excursion details of the vaccine were not provided. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459: US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014651: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
08/29/22 presents to EC ED for "Blocked J tube". PMHx of "esophageal cancer s/p chemotherapy and G-tube placement on 8/17" "HTN, recent COVID infection 8/21/2022"
Shortly after giving immunization patient c/o metallic taste in mouth.  No other symptom.  Concern is if this reaction would prevent her from receiving her second dose.
Fever, headache, fatigue and swelling in armpit about size of ping pong ball
The day after I receive my vaccination/since then I have been bleeding heavily and passing unusually large clots. Non stop bleeding. Painful.; I haven't had a period since before I was pregnant, and have been breast feeding my 7 month old so I have got one yet. The day after I receive my vaccination/since then  I have been bleeding heavily a; I haven't had a period since before I was pregnant, and have been breast feeding my 7 month old so I have got one yet. The day after I receive my vaccination/since then  I have been bleeding heavily; The day after I receive my vaccination/since then I have been bleeding heavily and passing unusually large clots. Non stop bleeding. Painful.; have been breast feeding her 7-month-old so she have got one yet; have been breast feeding her 7-month-old so she have got one yet; This is a spontaneous report from a contactable consumer (patient). A 31-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration, administered in Left arm on 20Aug2021 at the age of 31-years-old as dose 1, single for covid-19 immunisation. Medical history included latex allergy and food allergy from an unknown date. The patient was diagnosed with COVID-19 prior vaccination on an unspecified date. The patient's concomitant medications were not reported. The patient previously took tamiflu and experienced allergy. The patient did not receive other vaccine in four weeks of vaccination. The patient has not been tested for COVID-19 post vaccination. It was reported that the patient hasn't had a period since before she was pregnant, and have been breast feeding her 7-month-old so she have got one yet. On 21Aug2021, the day after she received her vaccination/since then she has been bleeding heavily and passing unusually large clots. Nonstop bleeding. Painful. She can't keep up with it. She was bleeding though a tampon and a pad hourly. No treatment was received for adverse events. Adverse events resulted in none of the above. The outcome of off-label use and drug use in unapproved population was unknown while outcome of other events was not recovered.  Follow-up activities are closed; Information about lot/batch number cannot be obtained.
Information has been received from a physician and a woman from a physician's office concerning a 63 year old female patient who on 02 JUL 2007 was vaccinated subcutaneously in the left arm with a first dose of zoster vaccine live (Oka/Merck) (lot# 657765/0585U).  two weeks after vaccination, on approximately 16 JUL 2007, the patient experienced multiple cold sores on both sides of her mouth, 4 on the outside and multiple on the inside.  No medical attention was sought.  There were no laboratory or diagnostic tests performed.  The outcome is reported as recovered on approximately 26 JUL 2007.  No product quality complaint was involved.  No more information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his arm) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in his arm). On 17-Feb-2021, PAIN IN EXTREMITY (soreness in his arm) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication was not provided. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up received, included significant information patient demographic.
Fever and brief syncope without loss of consciousness. Slept a little. Normal exam with physician except abrasion and bruise due to minor head injury with fall.
This is a non-serious spontaneous case from a health care professional reporting that a medical support member had ACCIDENTAL EXPOSURE to FluMist while vaccinating military personnel. The reporter determined the events to be unrelated to FluMist administration. This case is submitted according to the VAERS accelerated reporting agreement for FluMist. An unidentified medical support member developed headache and scratchy throat after accidental exposure during FluMist administration. Investigation into these events resulted in no definitive reason why the FluMist was responsible for these symptoms. The reporter determined the events to be unrelated to FluMist vaccination. Further information has been requested. Follow up - A 48 year old male medical support member developed headache and scratchy throat after accidental exposure during FLUMIST admisitration. Investigation into these events resulted in "no definitive reason" why the FLUMIST was responsible for "these symptoms." HEPA filters were put into the environment and since then, no body has gotten sick. The patient has recovered. The reporter believes military personnel that were vaccinated with FLUMIST were already sick and hence may have caused the individuals administering FLUMIST to have headache and scrarchy throat. The reporter determined the events to be unrelated to FLUMIST vaccination. Additional information received on 05Jan05 and 15Jan05 incorporated into above narrative. Additional information received on 04May05: patient name, gender and DOB; vaccine lot number.
After receiving the vaccine I experienced headaches, sever abdominal pain, fever and chills  The worse of the reactions happened approx. 12 hours after the shot.  It lasted about 48 hours.  I am still experiencing body aches, but they are not severe
PARTIAL EPILEPSY 12/30/2021 ACUTE DVT OF LEFT CALF MUSCULAR VEIN ACUTE DVT OF LEFT CALF MUSCULAR VEIN 12/30/2021 ACUTE DVT OF LEFT CALF MUSCULAR VEIN PARTIAL EPILEPSY 12/30/2021 CASE / CARE MGMT ACUTE DVT OF LEFT CALF MUSCULAR VEIN 12/30/2021 CASE / CARE MGMT
pt recvd vax in 22OCT92 & 2 days following 2nd dose devel flu-like sx & upper resp sx of sore throat & mildly persistent productive cough; No further details were provided;
Child had a seizure about 20 hrs after imm. It may have been febrile-temp not taken-child acting normal before and shortly afterward. Child had seizure with a few hrs after last imm. but found to have UTI at that time so felt it was probably febrile-but had 1-2 other seizures so put on Phenobarb
1 week after administration pt came down with small, raised, flesh-colored scaly bumps on all joints - fingers, toes... & worse on knees & elbows. Not painful, non-pruritic. Just very unsightly!
a 17 year old inadvertently receives the moderna vaccine; A spontaneous report was received from a health care professional concerning a 17-year old patient, unknown gender, who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, a 17 year old patient received their first dose of two planned dose of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the events was considered as recovered.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old) for mRNA-1273 (lot number unknown with no associated AEs reported.
Information has been received from a nurse concerning an 8-year-old male patient who on an unspecified date was vaccinated by injection with a 0.5 milliliter dose of varicella virus vaccine live (Oka/Merck) or measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (reporter unsure). On 26-MAR-2007 the patient experienced a mild case of chickenpox. The outcome is reported as not recovered. The patient sought unspecified medical attention. There was no product quality complaint involved. Additional information has been requested.
I experienced arm pain and arm got hot, itchy at injection site with swelling, fatigue, slept a lot for 3 days. Soreness and itching lasted about 10 days. Did not see a doctor
Pain at injection site - no c/o chills, fever, pain other areas - but did have severe weakness - says got better after 2-3 days - never had flu shot to hurt like that ever.
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium
I had COVID in July the adverse events were headache, body aches, fever and the chills were uncontrollable. this was far worse than the COVID event and it is just the 1st dose.
I had COVID in January 2021 but got the vaccine as soon as I could.  I had no unusual or long lasting side effects post recovery.  The day of and day after I received my vaccine had a typical reaction -- body aches, fever >102, etc.  On April 26th I started experiencing severe cramping which is unusual because I have a Mirena IUD.  This resulted in diarrhea and vomiting (from the pain, not nausea).  On the 27th I had the same symptoms plus a fever of 100.8.  The fever continued for another day or two.  On May 29th I again started experiencing cramping, diarrhea and vomiting.  On the May 30th I had cramping, diarrhea and starting running a temp greater than 100.4.  This continued off and on for 7 more days.  Some days I had severe cramping/diarrhea, some I ran fever up to 102.5, some days I experienced both.  The fever always starts mid afternoon to late evening.  On June 25th I started experiencing cramping, diarrhea and vomiting again.  On June 26th I had the same gastro/pelvic issues and my fever reached 100.9 and on the 28th it was up to 102.9.  The fever is always treated with alternating Tylenol/Advil every 4 hours and is still getting that high.
Severe body aches and sensitivity to touch (unable to get out of bed or walk without assistance). Sore throat. Coughing up blood and mucus. Progressing to severe headache (worst ever). Reoccurring fever. Sweating. Chills. Cellulitis on arm near but not on injection site that spreads in size over time. 5/17/2016-5/20/2016 (still dealing with side effects).
Caller would like to report AE; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Caller would like to report AE) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Caller would like to report AE). At the time of the report, ADVERSE EVENT (Caller would like to report AE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medications and Treatments were Reported.
Pt was given vaccine and immediately allowed to leave. Came out to waiting area, said she felt faint. Sat down, had ringing in her ears that lasted 10 minutes, confusion, had vision loss that lasted 3 minutes, passed out, vomited. Extremely fatigued, couldn't walk to car, had to go by wheelchair. 2 hours later still has extreme fatigue.
The first symptom was a sore throat, but it wasn't really bad. I did not sleep very well. I was exhausted. When I had COVID-19, I had very minor symptoms, and they were like those of a bad cold. I began having symptoms on 1/28/2023. My sore throat was worse on 1/29/2023. I took a home antigen test on 1/30/2023 and got a positive result. I began taking Paxlovid that day at 3 PM. I tested negative on 2/5/2023. On 2/8/2023, I tested positive again; I had a rebound. At the time of this writing, I feel back to normal.
Febrile reaction following flu and pneumovax immunization, with a temperature greater than 102, localized ecchymotic reaction of shoulder at injection site, myalgia, and arthralgia. She missed work 2 days due to this illness. Febrile illness, possible adverse drug reaction.
REDNESS, ITCHY, AND BLISTERS AROUND INJECTION SITE. THEN DEVELOPED HEADACHE, NAUSEA, AND TEMP OF 99.8.
In January of 2022, he started to experience a sudden and dramatic change in behavior, mood, emotional regulation, executive function, sleep, and attention with no prior history of any of these issues. These issues escalated and worsened between January and June. By the time school ended in June, his academic abilities had severely declined in math and reading, he was struggling with handwriting, and could barely function in the classroom. He was screened by his primary care doctor in February, a psychiatrist from March-June, received behavioral therapy through a psychotherapist from March-October, evaluated by a neurologist and sleep specialist in June, had tonsil and adenoid surgery performed by an ENT in July, and will have another sleep study performed in December. Many of his symptoms have dramatically improved since surgery but he still struggles with attention, focus, and impulsivity.
Vaccine administered day 0, 1000. Low fever and headache, beginning day 1 1600 lasting through day 2 2200. Treated with NSAIDs. Skin sloughing on feet first noticed on day 1, more prominent on day 2. No treatment given.
BODY ACHES TO THE POINT OF NONWEIGHT BEARING ON RIGHT KNEE ITCHY RASH ON FOREHEAD
The pt experienced Type II hypersensitivity reaction, as well as, arm soreness, redness and swelling after vaccination with Pneumovax.
w/in 5min of vax pt c/o n//v, got dizzy turned pale, BP 110/74;recovered w/in 10min;?syncope;
Moderna vaccine was administered to client on 10/05/2021, vaccine expired 10/01/2021.
Expired vaccine used; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 004m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Caller mentioned that "the CDC had just approved extended expiration dates" and wanted to know if it was extended. When asked the caller stated that there were no remaining vials unused of that lot number and agent reminded the caller that no patients should receive doses from expired vials. Dose was administered after 30-day Use by Date or after manufacturer date of expiry. Vial did not undergo any temperature excursions.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-701125 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-701125:Master case
Soreness and fever on next day (8/30/2018) followed by swelling on face day after (8/31/18).
Initially had a sore arm after first shot. That cleared up in two days. However, the sore arm returned and swelled up one week after the initial shot. It cleared up after 24 hours, and returned again one week later (two weeks after 1st shot). That cleared up after 24-48 hours.  Received second shot on April 14 2021 with no adverse reactions.  However, sore right arm seemed to return with no visible swelling around June 28th, lasting for about a week. Muscle felt sore and radiated down arm to elbow and wrists. Cleared up after a week.
Information has been received from a medical assistant, referring to an unspecified number of patients of unknown ages and genders. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with an improperly stored doses of VARIVAX lot # M035140 with expiration date on 03-AUG-2018 (strength, dose, administration route and anatomical location were not reported) for prophylaxis. No adverse effects were reported. The vaccines had an unspecified temperature excursion (reported as more than 14 Fahrenheit (F) and less than 46 F) during a time frame of 1125 hours. Also it was reported that no previous temperature excursions occurred or a digital data logger was involved. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested. ; Sender's Comments: US-009507513-1702USA006140:
fever; body pain; temperature is dropping; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, Caller said he received his vaccine last week, Since then he is experiencing fever, body pain and his temperature is dropping. He wanted to know what he needed to do about it. Because last Mar2020 He was positive for COVID. The outcome of the events was unknown.   Information on the batch/lot number has been requested.
I had Covid Nov 2020, lost of smell and taste fatigue, mild but never got taste fully back. Got moderna vaccine Apr 2021, then second dose May 2021. Just got booster Dec 21. Since the booster I had metal taste, then no taste, congested and fatigue. Itake like I have Covid. I?m convinced that I should not have gotten booster since I had Covid in the past. I?m sick .
Patient stated she felt fine and had no sx's after receiving injection on 9/7/17. On 9/14/17 in the evening she noticed bruising on arm. She woke up on the morning of 9/15/17 and was in discomfort and felt pain when trying to put on her pants. She called pharmacy to report, she was told by pharmacist to take some TYLENOL, which she did. Called back in a few hours and, patient said she was feeling much better and pain had decreased significantly.
Sudden onset of tightness/pressure/pain in chest, shortness of breath, fluttering sensation associated with heartbeat.   Duration: Tightness in chest - 8 hours Shortness of breath - 8 hours Fluttering sensation - 7-14 days
Moderna 2/24/21, 3/31/21, 10/26/21. Positive on 4/29/22
Site: Pain at Injection Site-Mild, Systemic: Joint Pain-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: jaw tightness and leg pain, resolved with time
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored RECOMBIVAX HB (dose, route of administration, lot# and expiration date were not provided). No adverse effects were reported. Temperature and time frame: 32 degrees Fahrenheit to 35 degrees Fahrenheit for 67 minutes and 47 degrees Fahrenheit to 77 degrees Fahrenheit for 139 minutes. Previous temperature excursion?: No. Was call because of a "data logger"?: Yes. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1709USA000878: US-009507513-1709USA000879: US-009507513-1709USA000880.